Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Ascentage, based on research at University of Michigan, has increased its total funding to more than $240m after closing a $150m series C round.
The Stanford-StartX Fund-backed electric scooter and bike rental service has raised $335m in a GV-led round that also included Uber.
Duke Management Company and Osage University Partners have invested in the genome editing technology spinout from Duke University.
UCL and Syncona have both returned for Freeline's series B round, which will spur clinical development of the spinout's gene therapy for haemophilia B.
Fresenius Medical Care will purchase a 19% stake in Humacyte, which closed a $75m series C round in March 2018.
Duke spinout Precision BioSciences, whose investors include Amgen and Baxter, has raised an initial $88m in series B funding out of a $110m target.
GV is reportedly leading a funding round for Lime, a bike-sharing platform also backed by NGP Capital and the Stanford-StartX fund.
Cambridge Innovation Capital has returned after backing CMR Surgical's two-tranche $46m series A round in 2016 and 2017.